Edgewise Therapeutics Inc. (EWTX) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Edgewise Therapeutics Inc...

    NASDAQ: EWTX · Real-Time Price · USD
    14.88
    -0.69 (-4.43%)
    At close: Sep 08, 2025, 3:59 PM
    14.88
    0.00%
    After-hours: Sep 08, 2025, 04:20 PM EDT

    Edgewise Therapeutics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 n/a n/a n/a n/a
    Cost of Revenue
    		 2.29M 1.73M 538K 272K
    Gross Profit
    		 -2.29M -1.73M -538K -272K
    Operating Income
    		 -158.83M -114.36M -22.08M -43.22M
    Interest Income
    		 25.02M 14.19M 2.66M 402K
    Pretax Income
    		 -133.81M -100.16M -67.64M -42.81M
    Net Income
    		 -133.81M -100.16M -67.64M -42.81M
    Selling & General & Admin
    		 31.87M 23.45M 5.47M 11.03M
    Research & Development
    		 126.97M 89.35M 16.61M 32.19M
    Other Expenses
    		 -2.29M -181K 49.58M n/a
    Operating Expenses
    		 156.54M 112.63M 71.66M 43.22M
    Interest Expense
    		 n/a n/a 4.02M n/a
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 158.83M 114.36M 71.66M 43.22M
    Income Tax Expense
    		 n/a n/a n/a n/a
    Shares Outstanding (Basic)
    		 92.41M 63.72M 53.59M 49.5M
    Shares Outstanding (Diluted)
    		 92.41M 63.72M 53.59M 49.5M
    EPS (Basic)
    		 -1.45 -1.57 -1.26 -0.86
    EPS (Diluted)
    		 -1.45 -1.57 -1.26 -0.86
    EBITDA
    		 -131.52M -112.81M -67.1M -42.94M
    EBIT
    		 -133.81M -114.36M -67.64M -43.22M
    Depreciation & Amortization
    		 2.29M 1.73M 538K 272K

    Add to Watchlist